Dr. Nasioudis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-662-2730
Education & Training
- Aristotle University of Thessaloniki School of MedicineClass of 2013
Certifications & Licensure
- PA State Medical License 2021 - 2024
Publications & Presentations
PubMed
- Premature adoption of adjuvant chemotherapy for locally advanced cervical carcinoma before the OUTBACK trial: cautionary tale on outcomes.Dimitrios Nasioudis, Nawar A Latif, Stefan Gysler, Robert L Giuntoli 2nd, Sarah H Kim
International Journal of Gynecological Cancer. 2024-12-02 - Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer.Giuseppe Caruso, Carrie L Langstraat, Amanika Kumar, Michaela E McGree, Angela J Fought
Gynecologic Oncology. 2024-12-01 - Secondary databases in gynecologic cancer research.Katherine Hicks-Courant, Emily Meichun Ko, Koji Matsuo, Alexander Melamed, Dimitrios Nasioudis
International Journal of Gynecological Cancer. 2024-10-07
Journal Articles
- Bacterial Vaginosis: A Critical Analysis of Current KnowledgeW J Ledger, D Nasioudis, BJOG: An International Journal of Obstetrics & Gynaecology
Press Mentions
- Is Adjuvant Chemo Warranted in Stage I Ovarian Clear Cell Carcinoma?May 14th, 2018
Other Languages
- French, Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: